Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cel-Sci
Cel-Sci
Cel-Sci's Successful Safety Review Not Yet Factored Into Valuation
Seeking Alpha
Fri, 11/2/12 - 11:10 am
Cel-Sci
Multikine
3 High Beta Liquid Small-Cap Biotechnology Stocks That Are Breaking Out
Seeking Alpha
Mon, 09/17/12 - 11:05 am
Cel-Sci
InterMune
Savient
Cel-Sci Corp, Synergy Pharmaceuticals Stocks Rise: Investors Should Start Paying Attention
Seeking Alpha
Tue, 05/1/12 - 11:29 am
Cel-Sci
Synergy Pharmaceuticals
Cel-Sci Offers Huge Potential Gains With Revolutionary Immunotherapy Anti-Cancer Drug
Seeking Alpha
Tue, 03/13/12 - 11:25 am
Cel-Sci
Teva Pharmaceuticals
Multikine
head and neck cancer
In Spite Of Dendreon's Woes, Other Players In The Sector Are Starting To Roll
Seeking Alpha
Mon, 03/5/12 - 11:13 am
Dendreon
Provenge
prostate cancer
Celldex
Agenus
Cel-Sci
ImmunoCellular
2 Biotechs On Teva's Radar Screen
Seeking Alpha
Mon, 02/6/12 - 11:21 am
Teva Pharmaceuticals
Cel-Sci
Bristol-Myers Squibb
Prolor
Past Bouncers And Others Biotech Plays Ready To Move
Seeking Alpha
Thu, 01/26/12 - 02:15 pm
Aeterna Zentaris
Affymax
Ampio
Bacterin International Holdings
GelTech
Cel-Sci
Ista
Inovio
Lpath
Nabi
Novavax
PharmAthene
CEL-SCI says Multikine Phase III trial launched in dozens of hospitals
The Fly on the Wall
Mon, 01/23/12 - 11:25 am
Cel-Sci
Multikine
head and neck cancer
CEL-SCI Corporation Releases Letter to Shareholders
Yahoo/BusinessWire
Sat, 01/21/12 - 01:08 pm
Cel-Sci
Multikine
head and neck cancer
Biopharma Stocks To Watch This Week
Seeking Alpha
Thu, 01/19/12 - 11:12 am
BioDelivery Sciences
Biovest International
Celldex
MannKind
NovaBay Pharmaceuticals
Keryx
ImmunoCellular
Cel-Sci
Dendreon
Generex
Human Genome Sciences
11 Biotech Bets For 2012
Seeking Alpha
Thu, 01/12/12 - 10:16 pm
Zalicus
Teva Pharmaceuticals
Spectrum
Astex
Aeterna Zentaris
Cel-Sci
Dendreon
Keryx
NPS Pharmaceuticals
Pharmacyclics
Questcor
Dendreon Leads the 'Now Generation' For Cancer Immunotherapeutic Treatment
Seeking Alpha
Mon, 07/4/11 - 09:20 am
Dendreon
prostate cancer
cancer immunotherapy
Cel-Sci
Cell Therapeutics
ImmunoCellular
Keryx
Teva Pharmaceuticals
Oncothyreon
Biotech Data Mining Comes Up Empty
TheStreet.com
Wed, 06/29/11 - 10:26 am
data mining
Cel-Sci
Apricus Biosciences
Osiris
Transdel
Agenus
Introgen
Cell Therapeutics
Biotech Clinical Trials Update for 3 Drug Manufacturers
Seeking Alpha
Mon, 06/27/11 - 05:44 pm
Pfizer
Cel-Sci
Bristol-Myers Squibb
Eliquis
Multikine
Cel-Sci: The Multikine Sweet 16
TheStreet.com
Tue, 05/3/11 - 02:36 pm
Cel-Sci
Multikine
CEL-SCI gets Israeli nod to commence phase III trial of multikine in head and neck cancer
pharmabiz
Sat, 04/2/11 - 11:15 am
Cel-Sci
Multikine
head and neck cancer
Biotech Stock Mailbag: Bio-Hazards
The Street
Sat, 03/26/11 - 10:00 am
Telik
Xoma
Genta
Cell Therapeutics
Discovery Labs
Cel-Sci
Biotech Stock Mailbag: Orexigen Therapeutics
TheStreet.com
Fri, 01/28/11 - 12:13 pm
Orexigen
Contrave
Arena Pharmaceuticals
Vivus
Avanir
Discovery Labs
Cel-Sci
CEL-SCI Investors Cheer a Bit Too Loudly
Motley Fool
Fri, 12/31/10 - 11:27 am
Cel-Sci
Multikine
head and neck cancer
Cel-Sci cuts losses, R&D triples
Bizjournals.com
Tue, 05/18/10 - 09:55 am
R&D
Cel-Sci
earnings
Pages
« first
‹ previous
1
2
3
4
next ›
last »